The risk of having a seizure is greatest during the first days of life. They are often the most common manifestation and diagnostic indication of neonatal brain injuries, such as hypoxic-ischaemic injury, infection, and stroke, amongst others. These injuries require timely diagnosis and treatment. However, less than 30% of neonatal seizures present with convulsive movements, and thus require electroencephalography (EEG) monitoring to correctly diagnose and subsequently treat the patient. EEG monitoring is a complex procedure, requiring specialised personnel such as a neurophysiologist, to configure the equipment and interpret the hours of resulting EEG traces. This often restricts the use of EEG monitoring to tertiary hospitals, and even in such hospitals, the expertise is not readily available for EEG to be used routinely without significant delays.
What is Neurobell:
Building on the previous research of the INFANT Research Centre in the field of AI-based interpretation of neonatal EEG, the Neurobell project is developing a medical device that can both record patients’ EEG and provide AI-based interpretation on a portable and wireless device. This means that neonatal seizure detection and alerts can be achieved in real-time without requiring specialised expertise.